Lifecare ASA is a Norway-based company that develops miniaturized and implantable nanobiosensors for correct and continuous monitoring of glucose and other biomarkers. Lifecare's activities are concentrated on the development of sensor for use as a medical product, initially the sensor Sencell for continuous monitoring of glucose (blood sugar) for people with diabetes. The technology is suitable for detecting and measuring a wide range of molecules that can occur in the human body, based on variations in osmotic pressure.

Employees

Sector

Biotechnology & Medical Research

Calendar

Earnings release - Q2 2026

More about the company

Quotes

Date	Price	Change	Volume
17/26/17	NOK 0.2850	-3.55%	7,93,744
16/26/16	NOK 0.2955	-0.17%	5,25,265
15/26/15	NOK 0.2960	+5.71%	14,02,079
14/26/14	NOK 0.2800	+1.45%	7,50,314
13/26/13	NOK 0.2760	0.00%	13,50,625

Real-time Oslo Bors

More quotes

Income Statement and Estimates

More financial data

EPS Estimates

Revisions to estimates

Annual profits - Rate of surprise

Company calendar

Market Closed - Oslo Bors Other stock markets 08:15:00 17/07/2026 pm IST			5-day change	1st Jan Change
0.2850 ^NOK	-3.55%		+3.26%	-91.26%

02/07	Lifecare Completes Production Transfer and Provides Update on Longevity Programme	CI
29/06	Lifecare Transfers Operations from Germany to Norway, UK	MT

Market Cap	8.5Cr 88.16L 77.04L 71.09L 65.53L 1.24Cr 85Cr 1.26Cr 8.5Cr 3.34Cr 42Cr 3.31Cr 3.24Cr 143.13Cr	P/E 2026 *	-0.75x	P/E 2027 *	-1.02x
Enterprise Value	12Cr 1.26Cr 1.1Cr 1.01Cr 93.29L 1.76Cr 120.87Cr 1.8Cr 12Cr 4.76Cr 59Cr 4.71Cr 4.61Cr 203.78Cr	EV / Sales 2026 *	-	EV / Sales 2027 *	24.6x
Free-Float	89.66%	Yield 2026 *	-	Yield 2027 *	-

02/07	Lifecare Completes Production Transfer and Provides Update on Longevity Programme	CI
29/06	Lifecare Transfers Operations from Germany to Norway, UK	MT
27/06	Lifecare ASA Discontinues Operations of Lifecare Germany GmbH	CI
10/06	Lifecare Completes First Six-Month Implant Evaluation With Continued Functionality and No Adverse Biological Response	CI
15/05	Lifecare ASA, Q1 2026 Earnings Call, May 15, 2026
15/05	Lifecare ASA Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
15/05	Lifecare Q1 operating loss NOK 31.5 mln	RE
23/04	Lifecare ASA Approves Board Appointments	CI
27/03	Lifecare ASA Announces Operational Restructuring And Centralization Of Operations	CI
27/03	Lifecare ASA Announces Discontinuation of the Business Operations of Lifecare Germany GmbH	CI
26/03	Lifecare ASA to Close German Operations, Consolidate Activities Under Planned Centralization	MT
16/03	Lifecare Chief Scientific Officer to Step Down	MT
14/03	Andreas Pfützner to Step Down as Chief Scientific Officer of Lifecare ASA	CI

02/07	LIFE: Update on production transfer and longevity programme	AQ
26/06	LIFE: Operational update regarding Lifecare Germany GmbH (i.L)	PU
22/06	LIFE: Independent tissue analysis confirms no adverse tissue response after six months of implantation	AQ
12/06	Lifecare ASA: Final results following expiry of exercise period for Warrants Series 2 issued in connection with Rights Issue	PU
10/06	Lifecare ASA: Mandatory notification of trade	PU

Lifecare ASA Share Price

Stocks

LIFE

NO0013355859

Biotechnology & Medical Research

Valuation: Lifecare ASA

Chart: Lifecare ASA

Latest news : Lifecare ASA

Last Transcript: Lifecare ASA

Analysts' recommendations: Lifecare ASA

Press Releases: Lifecare ASA

News in other languages: Lifecare ASA

Quotes and Performance

Course Extremes

Managers and Directors: Lifecare ASA

Other Biotechnology & Medical Research

Financials

Company Profile

Quotes

Income Statement and Estimates

Annual profits - Rate of surprise

1 day	-3.55%
1 week	+3.26%
Current month	-1.38%
1 month	-10.09%
3 months	-32.14%
6 months	-60.85%
Current year	-91.26%

1 week	0.27	0.3
1 month	0.27	0.38
Current year	0.27	2
1 year	0.27	23.5
3 years	0.27	82.16
5 years	0.27	82.16
10 years	0.27	117

Manager	Title	Age	Since
Joacim Holter CEO	Chief Executive Officer	50	07/09/2020
Petter Nielsen DFI	Director of Finance/CFO	-	01/04/2026
Torsten Ernst PRN	Corporate Officer/Principal	-	01/03/2024

Director	Title	Age	Since
Trine Teigland BRD	Director/Board Member	-	26/06/2020
Morten Foros Krohnstad CHM	Chairman	-	08/05/2021
Lutz Heinemann BRD	Director/Board Member	-	20/11/2020

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
LIFECARE ASA	-3.55%	+3.26%	-94.25%	-98.89%	88.16L
LONZA GROUP AG	-1.29%	-3.11%	-0.35%	+2.64%	4.92TCr
REVOLUTION MEDICINES, INC.	+3.90%	-0.39%	+386.06%	+588.97%	3.96TCr
BEONE MEDICINES AG	-1.70%	+4.46%	+5.93%	+61.54%	3.47TCr
IQVIA HOLDINGS INC.	-2.01%	-0.76%	+28.41%	-8.52%	3.44TCr
CELLTRION, INC.	+0.06%	+0.34%	+2.38%	+34.47%	2.71TCr
ASCENDIS PHARMA A/S	+0.46%	-3.49%	-	-	1.62TCr
MEDPACE HOLDINGS, INC.	-0.04%	-0.09%	+72.42%	+116.45%	1.54TCr
EUROFINS SCIENTIFIC SE	+1.12%	+1.91%	+14.54%	+15.44%	1.41TCr
ICON PUBLIC LIMITED COMPANY	0.00%	+1.36%	+18.43%	-31.23%	1.3TCr
Average	-0.30%	+0.35%	+48.17%	+75.65%	2.44TCr
Weighted average by Cap.	-0.05%	-0.18%	+79.44%	+122.30%

	2026 *	2027 *
Net sales	-	50L 5L 5L 4L 4L 7L 5Cr 7L 50L 19.67L 2.45Cr 19.48L 19.06L 8.42Cr
Net income	-8.6Cr -89.23L -77.98L -71.96L -66.33L -1.25Cr -86Cr -1.28Cr -8.6Cr -3.38Cr -42Cr -3.35Cr -3.28Cr -144.88Cr	-8.2Cr -85.08L -74.35L -68.61L -63.24L -1.19Cr -82Cr -1.22Cr -8.2Cr -3.23Cr -40Cr -3.2Cr -3.13Cr -138.14Cr
Net Debt	3.6Cr 37.35L 32.64L 30.12L 27.76L 52.33L 36Cr 53.49L 3.6Cr 1.42Cr 18Cr 1.4Cr 1.37Cr 61Cr	3.8Cr 39.43L 34.46L 31.8L 29.31L 55.24L 38Cr 56.46L 3.8Cr 1.49Cr 19Cr 1.48Cr 1.45Cr 64Cr